Welcome to Arterion
Arterion manufactures biomaterials, including artificial blood vessels, consisting of microbially derived cellulose for revascularisation of patients with cardiovascular diseases.
The manufacturing method is based on a novel technology that controls the life conditions of the microbe Gluconacetobacter xylinus.
The use of microbially derived cellulose will allow clinicians to use artificial blood vessels as replacement for vessels with an internal diamter of less than five millimetres. With today’s technology this is curently not possible.